Eris Lifesciences has informed that the Board of Directors of the Company, in their meeting held today, Monday, August 31, 2026, duly approved and took on record the following: Re-appointment of Mr. Sujesh Vasudevan as Independent Director of the Company Based on the recommendation of the Nomination & Remuneration Committee, the Board has considered and recommended to the members for their approval the re-appointment of Sujesh Vasudevan, as an Independent Director of the Company, for another period of 5 (Five) years commencing from July 25, 2027, up to July 24, 2032; Convening of 20th Annual General Meeting of the Members of the Company on Friday, September 25, 2026. The details as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. H0/49/14/14(7)2025-CFDPOD2/1/3762/2026 dated January 30, 2026, are given in the Annexure.
The above information is a part of company’s filings submitted to BSE.
